The Man, The Gland, The Dilemma

Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.
Part III

One evening a week for more than 10 years, a group of 15 to 25 men have met in a conference room in New York to talk about their prostate cancer. In the beginning, most of them swapped stories about their surgery or radiation, says Darryl Mitteldorf, a social worker who runs the group. Now, he says, more than half are doing “watchful waiting” — just monitoring their cancer to see if it grows.

“Some come in newly diagnosed and frightened, and they learn from the other guys that the word ‘cancer’ doesn’t necessarily mean it’s life-threatening,” Mr. Mitteldorf says.

Read More